Gilead Sciences (GILD) Tops Q2 EPS by 41c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $153.69 -1.8%
Revenue Growth %: -0.1%
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: -0.1%
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $2.01, $0.41 better than the analyst estimate of $1.60. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.72 billion.
GUIDANCE:
Gilead Sciences sees FY2024 EPS of $3.60-$3.90, versus the consensus of $3.71. Gilead Sciences sees FY2024 revenue of $27.1-27.5 billion, versus the consensus of $27.583 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin's Aide Says War In Ukraine Moving Toward An End - Vesti
- First Community Corp. (FCCO) Tops Q3 EPS by 5c
- Meta shares climb ahead of quarterly earnings report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
